Alcohol Industry Disruption

Recent studies reveal that GLP-1 drugs significantly reduce opioid overdoses and alcohol intoxication rates among individuals with substance use disorders. As the alcohol industry faces declining sales—Boston Beer down 9% and AB InBev down 15%—the potential impact of these medications could lead to a major restructuring. With a small percentage of drinkers responsible for a large portion of consumption, the loss of heavy drinkers could spell disaster for the industry.